GlassScriptPhysician profile
Mark B Sigler
NPI 1578799946
$3,388.35
in general payments reported to CMS, 2019-2025
27 companies · $139 in 2025
The $139 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,294 · 2020: $206 · 2022: $111 · 2023: $1,323 · 2024: $316 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $939 · Travel and Lodging: $779 · Education: $58.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $939.24 |
| Travel and Lodging | $779.40 |
| Education | $58.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $978.51 | 2023 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Astrazeneca Pharmaceuticals LP | $565.25 | 2019-2025 | Tezspire, Fasenra, Airsupra |
| Genzyme Corporation | $254.80 | 2019-2024 | |
| Genentech USA, INC. | $217.65 | 2019-2020 | |
| Glaxosmithkline, LLC. | $198.38 | 2019-2023 | Nucala |
| Regeneron Healthcare Solutions, INC. | $157.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.54 | 2019-2020 | |
| Amgen INC. | $93.64 | 2022-2023 | Tezspire |
| Electromed, INC. | $86.99 | 2019 | |
| Insmed, INC. | $84.29 | 2019-2024 | Arikayce |
| Intuitive Surgical, INC. | $83.34 | 2023 | Da Vinci Surgical System |
| Sanofi-Aventis U.S. LLC | $75.26 | 2019-2024 | |
| Mylan Specialty L.P. | $71.11 | 2019 | |
| Shire North American Group INC | $51.00 | 2019 | |
| Grifols USA, LLC | $48.14 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $39.45 | 2019 | |
| Allergan, INC. | $35.52 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.45 | 2020 | |
| Novartis Pharmaceuticals Corporation | $28.58 | 2019 | |
| Philips North America LLC | $25.47 | 2019 | |
| Janssen Pharmaceuticals, INC | $24.35 | 2019 | |
| Merck Sharp & Dohme LLC | $23.60 | 2019 | |
| Inogen, INC. | $18.48 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| E.R. Squibb & Sons, L.L.C. | $16.54 | 2019 | |
| Lilly USA, LLC | $16.46 | 2022 | |
| Circassia INC. | $16.36 | 2019 | |
| Veran Medical Technologies, INC. | $6.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sigler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.